Sat, Jul 26, 2014, 4:29 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Seattle Genetics Inc. Message Board

bioimmunomabman 328 posts  |  Last Activity: Jul 25, 2014 4:10 PM Member since: Nov 10, 2004
  • bioimmunomabman by bioimmunomabman Jul 21, 2014 4:47 PM Flag

    Hey moron #$%$, and don't make illegal, false statements about liquidity. You are not an auditor and have no clue what you are talking about. ARNA could cut costs and run for years on their current cash levels. You short liars should all be put in jail. How do you live with yourself trying to run down a business, mislead people...Can't you get a real job and add some value to society. Thou shall not bare false witness! I guess we are supposed to forgive #$%$ like you, but it's getting real old.

  • Reply to

    A couple of notes about insider transactions

    by tagetlocman Jul 17, 2014 9:31 AM
    bioimmunomabman bioimmunomabman Jul 21, 2014 1:46 PM Flag

    They all do this Biotech CEO=ATM and no concern for shareholders. They all think they own the company and their Boards and large shareholders do nothing to stop them. It's wrong and needs to change.

  • Reply to

    Insider transactions....;)

    by crecy_war_knight Jul 19, 2014 11:52 PM
    bioimmunomabman bioimmunomabman Jul 21, 2014 1:42 PM Flag

    BB's own so many shares, there's only one way for them to exit, acquisition. By any other means and the share price gets halved immediately after the first form 4. Recent hiring of CFO puts the exit out much further, so now we are at the mercy of management to get the filing right the first time. On the + side, it appears FDA wants the drug approved. On the - side, small biotech's are prone to making stupid mistakes on their first filing. I sure hope they GIRTFT.

  • bioimmunomabman bioimmunomabman Jul 21, 2014 1:36 PM Flag

    sure and I could live long enough to see a return on my investment, sale of the company, or additional dilution. Which will come first is the question. Upper left to lower right pattern is getting OLD!!!

  • Reply to


    by josef.novak Jul 21, 2014 11:20 AM
    bioimmunomabman bioimmunomabman Jul 21, 2014 12:24 PM Flag

    ARNA needs to show success in smoking cessation, or great weight loss gains with phen, or the losses could continue. I am becoming concerned, based on the stock's performance and the ability of shorts to exit while the price continues to decline.

  • bioimmunomabman by bioimmunomabman Jul 21, 2014 10:04 AM Flag

    It's just amazing, uncanny, even suspicious, their ability to time exec stock option grants at a 2-year low just a few months after their uncanny ability to sell high. How do they do it? Anyone else have questions, or concerns about the timing and size of these recent grants, particularly considering their abysmal performance in all areas over the past 12 months? Who wouldn't want a job where there are no expectations and lavish rewards. Maybe that's fine for a private company, but not for a public company unless the shareholders allow it. A theft has occurred IMO.

  • Reply to

    What's going on?

    by afro_bro_bro Jul 20, 2014 6:53 PM
    bioimmunomabman bioimmunomabman Jul 21, 2014 8:37 AM Flag

    management had their cheap shares awarded, now it can go up. It's time for this irresponsible, unresponsive, rubber-stamp BOD to be replaced. The performance of IMGN over the past 12 months has been terrible based on any reasonable evaluation, 1) stock price 2) pipeline advancement 3) Bus Dev... With the exception of the research team, execs should have not earned option awards and in fact, Junius and some other execs would have been fired by a company with reasonable standards/requirements for job performance IMO.

    How can shareholders remove the irresponsible IMGN BOD and stop the execs and BOD from stealing IMGN from the shareholders? I see a few options, 1) acquisition, 2) attracting the buying attention of a large shareholder activist, or 3) unite the largest current shareholders against the execs and board.

  • Reply to

    revenue from ovarian orphan drug status from FDA?

    by my_daddie Jul 15, 2014 3:29 PM
    bioimmunomabman bioimmunomabman Jul 18, 2014 1:13 PM Flag

    this is effing criminal and an outrage. Please let the company know about it.

  • Reply to

    How to kill a snake

    by eviljoe2013 Jul 18, 2014 10:49 AM
    bioimmunomabman bioimmunomabman Jul 18, 2014 11:14 AM Flag

    not so far it seems their plan is working well, much to our demise. They are exiting in an orderly fashion and seemingly at a profit for most of their shares in a sharply rising market. They are evil and I wish them suffering, at least in a financial sense, but so far it's not happening.

  • bioimmunomabman bioimmunomabman Jul 18, 2014 10:33 AM Flag

    It should be clear by now that ARNA is being opposed by well funded, well connected criminals. The sooner they exit the better. Maybe then the stock price can go up for a change. For today watch the crooks work the $5 close for opex.

  • bioimmunomabman bioimmunomabman Jul 18, 2014 10:21 AM Flag

    I don't recall any such discussions, so how can there be "no more' when there never was? Not that I don't agree Cramer and his sham of a company TSC and AF are working against ARNA and for the hedge fund shorts. One day they will be investigated and convicted IMO. Anyway, great growth in the numbers will one-day pay off.

  • Reply to

    Symphony #'s from John Galt on IV

    by simplyincome Jul 18, 2014 9:45 AM
    bioimmunomabman bioimmunomabman Jul 18, 2014 9:58 AM Flag

    How is the stock not flying on this news? $5 close for the market criminals opex today?

  • Reply to

    revenue from ovarian orphan drug status from FDA?

    by my_daddie Jul 15, 2014 3:29 PM
    bioimmunomabman bioimmunomabman Jul 17, 2014 9:03 PM Flag

    I am making every effort to put IMGN into play, or get it on the radar screen that a person of my "size" can do. I believe in shareholder rights as owners and that management's first job is to improve the stock price, which IMGN management has failed to do. There's too much LT value and potential for IMGN to be trading at this price level. I believe the main reason for the low valuation, or gap with SGEN is lack of belief in the credibility and decision making of IMGN's executive management team. The research team is fantastic, the phase I team is fine, technology is great, patents and NOL's have value. It's poor leadership, lack of Business Dev, weak IR/PR strategy, poor decisions/execution in mid to late development, Sr. executives/ nsider greed and selling...that is killing our value. I remain hopeful, but have lost all trust and patience.

  • Reply to

    When was the last time you hired a CFO?

    by crecy_war_knight Jul 17, 2014 1:21 PM
    bioimmunomabman bioimmunomabman Jul 17, 2014 4:49 PM Flag

    the poster clearly does not understand the difference between options and shares...

  • Reply to

    When was the last time you hired a CFO?

    by crecy_war_knight Jul 17, 2014 1:21 PM
    bioimmunomabman bioimmunomabman Jul 17, 2014 4:47 PM Flag

    Pfeffer is a terrible CFO, he allowed CELG to hold 80% of their assets in a phase II spin off that was once valued at 800MM then crashed to about $200MM when it was acquired. I warned him on multiple occasions that he and the dopey CEO were being irresponsible. These guys are all overpaid IMO unless they bring something to the table, wall street contacts, bus dev contacts, etc. The good news is that under $20.77 the options on those 320,000 shares are worthless, so he better hope for success.

  • Reply to

    revenue from ovarian orphan drug status from FDA?

    by my_daddie Jul 15, 2014 3:29 PM
    bioimmunomabman bioimmunomabman Jul 17, 2014 2:55 PM Flag

    I had a similarly pathetic response and have the same reaction, either clueless, which is certainly the case and/or there's some problem and they don't want to be seen hyping. Stock's performance is pathetic, shareholders must keep applying pressure with the BOD. Talking to IR is a waste of time, they are only interested in keeping their job, unable to say anything material and don't have a clue about the financial markets.

  • bioimmunomabman bioimmunomabman Jul 17, 2014 2:45 PM Flag

    problem is, they have been net buyers for the past few months and the price is still going down thanks to Jack and stagnant sales. ARNA needs some major news to know these shorts out, they are far too comfortable. It might take a sale, not sure anything else will work.

  • bioimmunomabman by bioimmunomabman Jul 17, 2014 8:48 AM Flag

    This guy is starting to tick me off, more insider selling and then a huge option award 320,000 to the new CFO, that's absurd. They are becoming just another bunch of typical greedy biotech leaders sucking the blood of their shareholders.

  • bioimmunomabman by bioimmunomabman Jul 17, 2014 8:37 AM Flag

    Don't reply to idiots that post FUD. These people should be put in jail!

  • Reply to

    Sanofi is buying!

    by slumdawg2011 Jul 16, 2014 5:48 PM
    bioimmunomabman bioimmunomabman Jul 17, 2014 8:33 AM Flag

    I have messaged senior level BD pros at Sanofi and Roche so far to point out the value of acquiring IMGN to them. I know people at Bayer and ABBV, so they will be next on the list. I wish SGEN would make a move, they would instantly expand their pipeline, gain some new/different technology, they could take out a ton of costs and get access to the Boston market of talent for technology (not management/leadership). Howard Pien has ties at BMS and I know some senior level market research people there, but they seem focused on immunotherapy, so likely not that interested. IMGN execs are not getting the job done and shareholders must take action.

34.89+0.20(+0.58%)Jul 25 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.